Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in …
JK Wong, HJ Lim, VC Tam, KW Burak… - Cancer treatment …, 2023 - Elsevier
Background Hepatocellular carcinoma (HCC) a leading cause of cancer mortality worldwide
and approximately one-third of patients present with intermediate-stage disease. The …
and approximately one-third of patients present with intermediate-stage disease. The …
Simultaneous Gemcitabine and Percutaneous CT‐Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Y Ma, Y Xing, H Li, B Liang, R Li, J Li, Z Li… - Journal of …, 2022 - Wiley Online Library
Background. Irreversible electroporation (IRE) is a new local ablation technique for
pancreatic cancer. The aim of this study is to analyse the safety and effectiveness of …
pancreatic cancer. The aim of this study is to analyse the safety and effectiveness of …
Prognostic Analysis on Different Tumor Sizes for 14634 Hepatocellular Carcinoma Patients
Z Chen, H Zheng, W Zeng, M Liu… - European Journal of …, 2023 - Wiley Online Library
Aim. This study investigated the effect of tumor size and other factors on the survival and
prognosis of hepatocellular carcinoma (HCC). Methods. All HCC populations based on the …
prognosis of hepatocellular carcinoma (HCC). Methods. All HCC populations based on the …